Prescribing cascade: calcium-channel blockers and diuretics

    Insights

    This study examined a common prescribing cascade involving calcium-channel blockers and diuretics in older adults with hypertension. The findings highlight potential medication-related harm and the need for improved prescribing practices in geriatric hypertension management.

    Area of Science:

    • Geriatric Medicine
    • Cardiovascular Pharmacology
    • Clinical Pharmacy

    Background:

    • Hypertension is a prevalent condition in older adults.
    • Prescribing cascades, where a drug is initiated to treat a side effect of another drug, are a concern in geriatric polypharmacy.
    • Calcium-channel blockers and diuretics are commonly prescribed for hypertension.

    Purpose of the Study:

    • To evaluate the frequency and impact of a specific prescribing cascade involving calcium-channel blockers and diuretics in older adults with hypertension.
    • To identify the clinical outcomes associated with this prescribing cascade.

    Main Methods:

    • Retrospective cohort study using administrative health data.
    • Inclusion of older adults (age 65+) diagnosed with hypertension.
    • Analysis of medication prescribing patterns and healthcare utilization.

    Main Results:

    • A significant proportion of older adults with hypertension were exposed to the calcium-channel blocker and diuretic prescribing cascade.
    • This cascade was associated with increased healthcare utilization and adverse events.
    • Specific patterns of drug initiation and discontinuation were identified.

    Conclusions:

    • The evaluated prescribing cascade is common in older adults with hypertension and may lead to suboptimal care.
    • Interventions aimed at optimizing antihypertensive prescribing in the elderly are warranted.
    • Further research should focus on preventing and mitigating prescribing cascades in this population.

    Related Concept Videos

    Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

    Antihypertensive Drugs: Action of Calcium Channel Blockers

    Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
    1.3K
    Heart Failure Drugs: Diuretics01:22

    Heart Failure Drugs: Diuretics

    Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
    641
    Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

    Antianginal Drugs: Calcium Channel Blockers and Ranolazine

    Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
    CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
    1.0K
    Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

    Antihypertensive Drugs: Potassium-Sparing Diuretics

    Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
    2.0K
    Antihypertensive Drugs: Thiazide-Class Diuretics01:15

    Antihypertensive Drugs: Thiazide-Class Diuretics

    Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
    1.4K
    Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

    Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

    Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
    Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
    1.3K